BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

ApaTech Ltd Announces Appointment Of Simon Cartmell As Chief Executive Officer


10/19/2005 5:11:01 PM

ApaTech™ Limited, a private orthopaedics company specialising in synthetic bone graft substitutes, announced today the appointment of Simon Cartmell as Chief Executive Officer. Simon Cartmell has 23 years pharmaceutical, healthcare and biotechnology industry experience. He spent 17 years at GlaxoWellcome in a number of UK and global roles, including Therapy Area Director, Infectious Diseases and Hepatitis, with international research, development and commercial responsibility for this £1.8 billion business. Simon joined Vernalis plc (formerly Vanguard Medica plc) as Chief Operating Officer in 1998 before joining the main board of Celltech plc as Chief Executive Officer for Celltech Pharmaceuticals in mid 2000. In this role he was responsible for the performance and development of the global pharmaceuticals business, including supply operations. More recently Simon has been interim CEO of Entomed sa, a Strasbourg based, early stage biotech, where he remains a Non Executive Director. He is also Non Executive Chairman of Curidium Ltd.


   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES